Hyperthermia treatment prevents angiotensin II-mediated atrial fibrosis and fibrillation via induction of heat-shock protein 72
Hyperthermia treatment prevents angiotensin II-mediated atrial fibrosis and fibrillation via induction of heat-shock protein 72
复制标题
DOI:
10.1016/j.yjmcc.2007.08.005
复制
发表时间:
2007-11-01
影响因子:
5
通讯作者:
Yoshimatsu, Hironobu
中科院分区:
文献类型:
--
作者:
Wakisaka, Osamu;Takahashi, Naohiko;Yoshimatsu, Hironobu
We tested the hypothesis that atrial fibrosis and atrial fibrillation (AF) evoked by angiotensin 11 (All) could be prevented by the induction of heat-shock protein 72 (HSP72) by hyperthermia (HT). In cultured atrial fibroblasts isolated from male Sprague-Dawley rats, HT (42 degrees C) was applied for 30 min. All (100 nmol/L) was added to the medium 8 h later. HT induced the expression of HSP72, which was associated with the attenuation of All-induced extracellular signal-regulated kinase (ERK1/ERK2) phosphorylation, a-smooth muscle actin (alpha-SMA) expression, transforming growth factor-beta(1) secretion, collagen synthesis, and expression of collagen type I and tissue inhibitor of metalloproteinases-1. A small interfering RNA targeting HSP72 abolished these anti-fibrotic effects of HT. In male Sprague-Dawley rats in vivo, an osmotic mini-pump was subcutaneously implanted for continuous infusion of All (400 ng/kg/min). Whole-body HT (43 degrees C, 20 min) was applied 24 h before and 7, 14, and 21 days after the start of the All infusion. Repeated HT led to the induction of HSP72 expression, which resulted in an attenuation of All-induced left atrial fibrosis. In an electrophysiological study using isolated perfused heart, continuous All caused slowing of interatrial conduction without affecting atrial refractoriness. In All-treated hearts, extrastimuli from the right atrial appendage resulted in a high incidence of repetitive atrial responses, which were suppressed by treatment with HT. Our results suggest that HT treatment is effective in suppressing All-mediated atrial fibrosis and AF via induction of HSP72 at least in parts, and is thus expected to be a novel strategy for prevention of AF. (c) 2007 Elsevier Inc. All rights reserved.